Compare DERM & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | KRMD |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 192.5M |
| IPO Year | 2021 | 2019 |
| Metric | DERM | KRMD |
|---|---|---|
| Price | $6.24 | $4.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $12.67 | $6.50 |
| AVG Volume (30 Days) | ★ 157.2K | 125.3K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.72 | ★ 53.85 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $61,858,000.00 | $41,127,366.00 |
| Revenue This Year | $39.72 | $20.32 |
| Revenue Next Year | $63.24 | $17.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 10.20 | ★ 22.23 |
| 52 Week Low | $4.31 | $3.20 |
| 52 Week High | $9.56 | $6.61 |
| Indicator | DERM | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.81 | 44.91 |
| Support Level | $5.80 | $3.86 |
| Resistance Level | $6.59 | $4.26 |
| Average True Range (ATR) | 0.37 | 0.19 |
| MACD | -0.13 | -0.03 |
| Stochastic Oscillator | 17.93 | 34.39 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.